Todd C Davis Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd C Davis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd C Davis. Todd C Davis is Director in LIGAND PHARMACEUTICALS INC ($LGND) and Director in Vaxart, Inc. ($AVIR) and Director in BIODELIVERY SCIENCES INTERNATIONAL INC ($BDSI).
Latest Insider Trading Transactions of Todd C Davis
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BDSI, LGND, VXRT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2021 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 195.91 | 2,474 | 484,681 | 0 | |
| Feb 12 2021 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 195.91 | 2,474 | 484,681 | 50,152 | 47.7 K to 50.2 K (+5.19 %) |
| Feb 12 2021 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 213.14 | 5,083 | 1,083,410 | 47,678 | 52.8 K to 47.7 K (-9.63 %) |
| Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 113.50 | 2,456 | 278,756 | 0 | |
| Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 113.50 | 2,456 | 278,756 | 52,761 | 50.3 K to 52.8 K (+4.88 %) |
| Aug 20 2020 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Sell | S | 4.99 | 50,000 | 249,500 | 217,914 | 267.9 K to 217.9 K (-18.66 %) |
| Aug 11 2020 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Option Exercise | M | 0.00 | 30,000 | 0 | 45,000 | |
| Aug 11 2020 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Option Exercise | M | 0.00 | 30,000 | 0 | 45,000 | |
| Aug 11 2020 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Buy | M | 0.00 | 30,000 | 0 | 267,914 | 237.9 K to 267.9 K (+12.61 %) |
| Aug 11 2020 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Buy | M | 0.00 | 30,000 | 0 | 267,914 | 237.9 K to 267.9 K (+12.61 %) |
| Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 | |
| Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 831 | 0 | 50,305 | 49.5 K to 50.3 K (+1.68 %) |
| Jun 09 2020 | VXRT | Vaxart, Inc. | Davis Todd C | Director | Option Exercise | A | 2.39 | 65,700 | 157,023 | 65,700 | |
| Apr 30 2020 | VXRT | Vaxart, Inc. | Davis Todd C | Director | Sell | S | 3.28 | 60,000 | 196,500 | 120,000 | 180 K to 120 K (-33.33 %) |
| Nov 20 2019 | AVIR | Vaxart, Inc. | Davis Todd C | Director | Option Exercise | A | 0.31 | 54,720 | 16,963 | 54,720 | |
| Nov 19 2019 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Sell | S | 6.11 | 200,000 | 1,222,000 | 237,914 | 437.9 K to 237.9 K (-45.67 %) |
| Aug 15 2019 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Option Exercise | M | 0.00 | 18,123 | 0 | 75,000 | |
| Aug 15 2019 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Buy | M | 0.00 | 18,123 | 0 | 437,914 | 419.8 K to 437.9 K (+4.32 %) |
| Aug 05 2019 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | P | 93.59 | 1,000 | 93,594 | 49,474 | 48.5 K to 49.5 K (+2.06 %) |
| Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 113.59 | 4,071 | 462,425 | 4,071 | |
| Jun 07 2019 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 835 | 0 | 48,474 | 47.6 K to 48.5 K (+1.75 %) |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 119.30 | 2,329 | 277,850 | 0 | |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 89.75 | 2,754 | 247,172 | 0 | |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 119.30 | 2,329 | 277,850 | 47,639 | 45.3 K to 47.6 K (+5.14 %) |
| Oct 15 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 89.75 | 2,754 | 247,172 | 45,310 | 42.6 K to 45.3 K (+6.47 %) |
| Oct 09 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 253.99 | 2,500 | 634,978 | 42,556 | 45.1 K to 42.6 K (-5.55 %) |
| Aug 24 2018 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Option Exercise | C | 1.80 | 75 | 135 | 0 | |
| Aug 24 2018 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Buy | C | 0.00 | 416,667 | 0 | 419,791 | 3.1 K to 419.8 K (+13,337.61 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 239.50 | 3,167 | 758,497 | 45,056 | 48.2 K to 45.1 K (-6.57 %) |
| Aug 17 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 239.93 | 5,833 | 1,399,505 | 48,223 | 54.1 K to 48.2 K (-10.79 %) |
| Aug 16 2018 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Option Exercise | M | 0.00 | 3,124 | 0 | 93,123 | |
| Aug 16 2018 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Buy | M | 0.00 | 3,124 | 0 | 3,124 | 0 to 3.1 K |
| Aug 03 2018 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Option Exercise | A | 2.93 | 48,123 | 141,000 | 48,123 | |
| Aug 03 2018 | BDSI | BIODELIVERY SCIENC ... | Davis Todd C | Director | Option Exercise | A | 0.00 | 96,247 | 0 | 96,247 | |
| Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
| Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 76.77 | 2,474 | 189,929 | 2,474 | |
| Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 493 | 0 | 54,056 | 53.6 K to 54.1 K (+0.92 %) |
| Jun 21 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 493 | 0 | 54,056 | 53.6 K to 54.1 K (+0.92 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 151.90 | 12,335 | 1,873,709 | 53,563 | 65.9 K to 53.6 K (-18.72 %) |
| Feb 27 2018 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Sell | S | 153.58 | 4,835 | 742,536 | 65,898 | 70.7 K to 65.9 K (-6.84 %) |
| Dec 27 2017 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Gift | G | 0.00 | 74 | 0 | 70,733 | 70.8 K to 70.7 K (-0.10 %) |
| May 26 2017 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 113.50 | 2,456 | 278,756 | 2,456 | |
| May 26 2017 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 666 | 0 | 70,807 | 70.1 K to 70.8 K (+0.95 %) |
| Dec 29 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Gift | G | 0.00 | 48 | 0 | 70,141 | 70.2 K to 70.1 K (-0.07 %) |
| Nov 01 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 67.53 | 3,312 | 223,659 | 0 | |
| Nov 01 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 53.34 | 3,333 | 177,782 | 0 | |
| Nov 01 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 32.30 | 7,335 | 236,921 | 0 | |
| Nov 01 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 67.53 | 3,312 | 223,659 | 70,189 | 66.9 K to 70.2 K (+4.95 %) |
| Nov 01 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 32.30 | 7,335 | 236,921 | 66,877 | 59.5 K to 66.9 K (+12.32 %) |
| Nov 01 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 53.34 | 3,333 | 177,782 | 59,542 | 56.2 K to 59.5 K (+5.93 %) |
| May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 119.30 | 2,329 | 277,850 | 2,329 | |
| May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 188 | 0 | 56,209 | 56 K to 56.2 K (+0.34 %) |
| May 25 2016 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 622 | 0 | 56,021 | 55.4 K to 56 K (+1.12 %) |
| Dec 09 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Gift | G | 0.00 | 50 | 0 | 55,399 | 55.4 K to 55.4 K (-0.09 %) |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 17.88 | 2,500 | 44,700 | 0 | |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 12.53 | 7,335 | 91,908 | 0 | |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 10.12 | 7,335 | 74,230 | 0 | |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | M | 8.58 | 2,500 | 21,450 | 0 | |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 12.53 | 7,335 | 91,908 | 55,449 | 48.1 K to 55.4 K (+15.25 %) |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 10.12 | 7,335 | 74,230 | 48,114 | 40.8 K to 48.1 K (+17.99 %) |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 8.58 | 2,500 | 21,450 | 40,779 | 38.3 K to 40.8 K (+6.53 %) |
| Aug 06 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Buy | M | 17.88 | 2,500 | 44,700 | 38,279 | 35.8 K to 38.3 K (+6.99 %) |
| Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 89.75 | 2,754 | 247,172 | 2,754 | |
| Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 501 | 0 | 35,779 | 35.3 K to 35.8 K (+1.42 %) |
| Apr 27 2015 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 925 | 0 | 35,278 | 34.4 K to 35.3 K (+2.69 %) |
| Jun 02 2008 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Jun 04 2007 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 6.61 | 10,000 | 66,100 | 10,000 | |
| Mar 05 2007 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 11.39 | 20,000 | 227,800 | 20,000 |
Page: 1